Green Thumb Industries GTBIF
OTC GTBIF
$7.62 +0.37 (+5.10%)
At close: Aug 19, 2026 · 3:59 PM UTC

Green Thumb Industries (GTBIF) Income towards Parent Company (2019 - 2026)

Green Thumb Industries' (GTBIF) quarterly Income towards Parent Company came in at $15.0 million in Q1 2026, up 79.11% YoY from $8.4 million in Q1 2025, and down 93.04% on a QoQ basis from $216.3 million in Q4 2025.

Green Thumb Industries (GTBIF) Income towards Parent Company (2019 - 2026) Analysis & Trends

Green Thumb Industries (GTBIF) has 8 years of Income towards Parent Company data on file, last reported at $15.0 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 79.11% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $255.8 million (up 63.51% YoY) and the FY2025 annual result came in at $249.2 million, up 38.89% from the prior year.
  • Income towards Parent Company retreated to $15.0 million in Q1 2026, from $216.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $216.3 million in Q4 2025 to a low of -$99.0 million in Q4 2022.
  • A 5-year average of $31.3 million and a median of $15.0 million in 2026 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 166.62% — and 2024, when it surged 233.31%.
  • Tracing GTBIF's Income towards Parent Company over 5 years: stood at -$99.0 million in 2022, then jumped by 190.29% to $89.4 million in 2023, then surged by 32.44% to $118.4 million in 2024, then surged by 82.7% to $216.3 million in 2025, then plunged by 93.04% to $15.0 million in 2026.
  • The last three Income towards Parent Company figures came in at $15.0 million (Q1 2026), $216.3 million (Q4 2025), and $23.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.92 Bn 42.96 Bn -
2 Teva Pharmaceutical Industries 43.19 Bn 39.53 Bn 2.15 Bn
3 Zoetis 31.74 Bn 30.06 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.67 Bn 22.87 Bn 5.10 Bn
5 United Therapeutics 22.22 Bn 19.56 Bn 683.80 Mn
6 Viatris 18.71 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn
8 Elanco Animal Health 11.80 Bn 11.27 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Green Thumb Industries 1.66 Bn 1.37 Bn 137.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.43 Mn
Mar 31, 2026 15.05 Mn
Dec 31, 2025 216.27 Mn
Sep 30, 2025 23.80 Mn
Jun 30, 2025 732,000.00
Mar 31, 2025 8.40 Mn
Dec 31, 2024 118.37 Mn
Sep 30, 2024 8.78 Mn
Jun 30, 2024 20.92 Mn
Mar 31, 2024 31.35 Mn
Dec 31, 2023 89.38 Mn
Sep 30, 2023 10.81 Mn
Jun 30, 2023 13.69 Mn
Mar 31, 2023 9.41 Mn
Dec 31, 2022 -98.99 Mn
Sep 30, 2022 10.15 Mn
Jun 30, 2022 24.73 Mn
Mar 31, 2022 29.69 Mn
Dec 31, 2021 148.61 Mn
Sep 30, 2021 21.59 Mn